Fundacion Clinic Per A La Recerca Biomédica
Clinical trials sponsored by Fundacion Clinic Per A La Recerca Biomédica, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dye combo could spare ovarian cancer patients unnecessary surgery Results expected Oct 2026 (estimated)
- Could a simple injection cut blood transfusions in liver transplants? Results expected Dec 2026 (estimated)
- Pill power: oral antibiotics may match IVs for serious heart infection Results expected Dec 2026 (estimated)
- Kitchen cure: culinary medicine may help reverse metabolic syndrome Results expected Mar 2027 (estimated)
- Can a simple protein infusion save kidneys in liver patients? Results expected Aug 2027 (estimated)
-
Drug cocktail aims to stop liver cancer recurrence after surgery
Disease control Recruiting nowThis study tests whether combining two drugs, atezolizumab and bevacizumab, given before and after surgery can help prevent liver cancer from coming back. It enrolls adults with a type of liver cancer that can be surgically removed but has a high risk of recurrence. Participants …
Phase 2 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Pill power: oral antibiotics may match IVs for serious heart infection
Disease control Recruiting nowThis study compares oral antibiotics to intravenous (IV) antibiotics for treating infective endocarditis, a serious heart infection. Researchers want to see if taking pills at home works as well as getting IV treatment in a clinic. The trial involves 360 adults with specific type…
Phase 4 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a simple injection cut blood transfusions in liver transplants?
Disease control Recruiting nowThis study tests if a drug called darbepoetin can lower the need for blood transfusions during liver transplant surgery. About 140 adults on the liver transplant waiting list with low hemoglobin will receive either the drug or a placebo. The goal is to see if the drug safely redu…
Phase 3 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a gas-busting ingredient in colonoscopy prep help spot more cancers?
Diagnosis Recruiting nowThis trial compares two bowel-cleansing solutions used before screening colonoscopy for colorectal cancer. One contains simethicone, an anti-gas agent, while the other does not. The study aims to see if the simethicone-containing solution helps doctors detect more adenomas (preca…
Phase 4 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New dye combo could spare ovarian cancer patients unnecessary surgery
Diagnosis Recruiting nowThis pilot study is testing whether a combination of two dyes (technetium-99m albumin nanocolloid and indocyanine green) can accurately identify the first lymph node where ovarian cancer might spread. The goal is to improve surgical staging and potentially avoid removing many lym…
Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Could a custom vaccine stop cancer before it starts in lynch syndrome?
Prevention Recruiting nowThis early-stage trial tests a personalized vaccine made from a person's own immune cells (dendritic cells) loaded with unique proteins found in Lynch syndrome-related cancers. The goal is to train the immune system to recognize and attack precancerous cells, potentially preventi…
Phase 1 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC